Bismuth Subsalicylate, Metronidazole, an... Clinical Trials

• Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
  ClinicalTrials.gov Identifier: NCT00002682 - Active, not recruiting
  mucosa-associated lymphoid tissue; stage I diffuse small lymphocytic/marginal zone lymphoma
  
• Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
  ClinicalTrials.gov Identifier: NCT00003151 - Active, not recruiting
  contiguous stage II diffuse small lymphocytic/marginal zone lymphoma; stage I diffuse small lymphocytic/marginal zone lymphoma
  
• Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers
  ClinicalTrials.gov Identifier: NCT00066066 - Recruiting
  Periodontitis; Periodontal Diseases
  
• Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
  ClinicalTrials.gov Identifier: NCT00091247 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment
  ClinicalTrials.gov Identifier: NCT00182429 - Completed
  Clostridium Enterocolitis; Antibiotic-Associated Diarrhea; Pseudomembranous Colitis; Pseudomembranous Enterocolitis; Pseudomembranous Enteritis
  
• Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms
  ClinicalTrials.gov Identifier: NCT00243893 - Active, not recruiting
  Aneurysms; Arteriovenous Malformations
  
• Evaluation of the efficacy and safety of a high induction dose of Pegasys in combination with Copegus in patients with Chronic Hepatitis C who did not respond to previous treatment with PEG-Intron in combination with Rebetol/Ribavirin.
  ClinicalTrials.gov Identifier: NCT00087646 - Active, not recruiting
  Hepatitis
  
• Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-Abdominal Infection
  ClinicalTrials.gov Identifier: NCT00195351 - Recruiting
  Appendicitis; Cholecystitis; Cross Infection; Diverticulitis; Peritonitis
  
• Metronidazole for Pulmonary Tuberculosis (South Korea)
  ClinicalTrials.gov Identifier: NCT00425113 - Recruiting
  Tuberculosis; Multi-Drug Resistant Tuberculosis
  
• Response of Clostridium Difficile Infection to Metronidazole Therapy
  ClinicalTrials.gov Identifier: NCT00304369 - Recruiting
  Clostridium Enterocolitis; Pseudomembranous Colitis; Antibiotic-Associated Colitis
  
• Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00509639 - Recruiting
  Crohn's Disease
  
• Treating Periodontal Infection: Effects on Glycemic Control in People with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00016835 - Active, not recruiting
  Periodontal Disease; Diabetes Mellitus, Non-Insulin-Dependent
  
• A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease
  ClinicalTrials.gov Identifier: NCT00453349 - Recruiting
  Pelvic Inflammatory Disease
  
• Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling
  ClinicalTrials.gov Identifier: NCT00469261 - Recruiting
  Myocardial Infarction; Ventricular Remodeling
  
• Microbial Associations in Periodontal Health and Disease
  ClinicalTrials.gov Identifier: NCT00066001 - Recruiting
  Periodontitis; Periodontal Diseases
  
• Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-Abdominal Infection (cIAI)
  ClinicalTrials.gov Identifier: NCT00230971 - Recruiting
  Appendicitis; Cholecystitis; Diverticulitis; Intra-Abdominal Abscess; Intra-Abdominal Infection; Peritonitis
  
• Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa
  ClinicalTrials.gov Identifier: NCT00336154 - Not yet recruiting
  Epidermolysis Bullosa
  
• Study of Antibiotics in the Treatment of Colonic Crohn''s Disease
  ClinicalTrials.gov Identifier: NCT00257699 - Recruiting
  Crohn''s Disease
  
• Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00367055 - Active, not recruiting
  Type 2 Diabetes
  
• Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX
  ClinicalTrials.gov Identifier: NCT00479583 - Recruiting
  Cancer
  
• To study the safety (free of harmful side effects) and effectiveness (prevention of structural joint damage) of MRA, in combination with methotrexate, compared to placebo in combination with methotrexate in rheumatoid arthritis patients
  ClinicalTrials.gov Identifier: NCT00106535 - Active, not recruiting
  Rheumatoid Arthritis
  
• COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)
  ClinicalTrials.gov Identifier: NCT00132899 - Active, not recruiting
  Crohn''s Disease
  
• To study the safety of and ability of MRA, an investigational drug, in reducing the signs and symptoms of rheumatoid arthritis in combination with DMARD therapy as compared to placebo in combination with DMARD therapy
  ClinicalTrials.gov Identifier: NCT00106574 - Active, not recruiting
  Rheumatoid Arthritis
  
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002784 - Active, not recruiting
  Breast Cancer
  
• ONTARGET: ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria Parallel Trial. TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease Trial.
  ClinicalTrials.gov Identifier: NCT00153101 - Active, not recruiting
  Cardiovascular Diseases
  
• Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients
  ClinicalTrials.gov Identifier: NCT00447967 - Recruiting
  Gastric Cancer
  
• Trial of UK-427,857 in Combination with Zidovudine/Lamivudine versus Efavirenz in Combination with Zidovudine/Lamivudine for the Treatment of HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00098293 - Active, not recruiting
  HIV Infection
  
• Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-Coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.
  ClinicalTrials.gov Identifier: NCT00425308 - Recruiting
  Renal Transplantation
  
• Phase 1-2a Dose-Ranging Study of TLK286 in Combination with Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00047801 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• An Investigational Combination Vaccine Given to People Who Are Not Infected with HIV
  ClinicalTrials.gov Identifier: NCT00027365 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• ARQ 501 in Combination with Gemcitabine in Subjects with Cancer
  ClinicalTrials.gov Identifier: NCT00102700 - Active, not recruiting
  Pancreatic Cancer; Adenocarcinoma
  
• A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00337987 - Recruiting
  Peripheral T-Cell Lymphoma
  
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00014495 - Recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Phase I FOLFOX Combination
  ClinicalTrials.gov Identifier: NCT00499850 - Active, not recruiting
  Advanced Colorectal Carcinoma
  
• Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation
  ClinicalTrials.gov Identifier: NCT00154440 - Recruiting
  Lymphoma, Mucosa-Associated Lymphoid Tissue; B-cell Non-Hodgkin''y Lymphoma of the stomach, primary gastric
  
• Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin
  ClinicalTrials.gov Identifier: NCT00362206 - Active, not recruiting
  Hyperlipidemia
  
• Docetaxel and Lapatinib With or Without Combination Chemotherapy or Docetaxel and Trastuzumab With Combination Chemotherapy in Treating Women With Locally Advanced, Inflammatory, or Resectable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00450892 - Recruiting
  Breast Cancer
  
• A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers.
  ClinicalTrials.gov Identifier: NCT00177255 - Active, not recruiting
  Cancer
  
• Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00193570 - Active, not recruiting
  Cancer
  
• Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
  ClinicalTrials.gov Identifier: NCT00295646 - Active, not recruiting
  Breast Cancer
  
• Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
  ClinicalTrials.gov Identifier: NCT00305084 - Active, not recruiting
  Cancer
  
• Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients
  ClinicalTrials.gov Identifier: NCT00383708 - Active, not recruiting
  Acromegaly
  
• Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
  ClinicalTrials.gov Identifier: NCT00507091 - Active, not recruiting
  Metastatic; Colorectal; Adenocarcinoma
  
• Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00019864 - Active, not recruiting
  Cardiac Toxicity; Sarcoma
  
• Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.
  ClinicalTrials.gov Identifier: NCT00200694 - Active, not recruiting
  Heavy Proteinuria
  
• Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
  ClinicalTrials.gov Identifier: NCT00249977 - Active, not recruiting
  Solid Tumors; Cancer
  
• Safety and Immune Response of Different Pediatric Combination Vaccines.
  ClinicalTrials.gov Identifier: NCT00255047 - Active, not recruiting
  Diphtheria; Polio; Pertussis
  
• Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00193583 - Active, not recruiting
  Cancer
  
• Study of Combination Immunotherapy for the Generation of HER-2/Neu Specific Cytotoxic T Cells
  ClinicalTrials.gov Identifier: NCT00194714 - Active, not recruiting
  Breast Cancer
  
• Effect of TAK-475 and Simvastatin Alone or in Combination on Blood Cholesterol Levels.
  ClinicalTrials.gov Identifier: NCT00286481 - Active, not recruiting
  Hyperlipidemia; Hypercholesterolemia
  
• Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00374660 - Active, not recruiting
  Liver Cancer
  
• Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal
  ClinicalTrials.gov Identifier: NCT00374803 - Active, not recruiting
  Kidney Transplant
  
• Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone
  ClinicalTrials.gov Identifier: NCT00493766 - Active, not recruiting
  Hormone Refractory Prostate Cancer
  
• Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin
  ClinicalTrials.gov Identifier: NCT00288431 - Active, not recruiting
  Cancer; Sarcoma
  
• Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114
  ClinicalTrials.gov Identifier: NCT00296257 - Active, not recruiting
  Rheumatoid Arthritis (RA)
  
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on
  ClinicalTrials.gov Identifier: NCT00350779 - Active, not recruiting
  Diabetes Mellitus, Type II
  
• Safety and Efficacy of Valsartan Versus Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00396656 - Active, not recruiting
  Hypertension
  
• An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure
  ClinicalTrials.gov Identifier: NCT00402103 - Active, not recruiting
  Hypertension
  
• Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)
  ClinicalTrials.gov Identifier: NCT00523406 - Active, not recruiting
  Macular Degeneration
  
• Tarceva® as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
  ClinicalTrials.gov Identifier: NCT00294762 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL
  ClinicalTrials.gov Identifier: NCT00185445 - Active, not recruiting
  Non Hodgkin Lymphoma
  
• Open-Label Study to Evaluate the Efficacy and Safety of an Extended-Cycle, Low Dose Combination Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00196326 - Active, not recruiting
  Contraception
  
• Study Comparing the Safety and Efficacy of ABT-335 and Simvastatin Combination Therapy to Monotherapy in Subjects With Mixed Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00300456 - Active, not recruiting
  Dyslipidemias
  
• A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
  ClinicalTrials.gov Identifier: NCT00335270 - Active, not recruiting
  HIV
  
• A Sub-Study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin
  ClinicalTrials.gov Identifier: NCT00468039 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• An Open-Label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine
  ClinicalTrials.gov Identifier: NCT00165880 - Active, not recruiting
  Metastatic Breast Cancer
  
• A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
  ClinicalTrials.gov Identifier: NCT00333112 - Active, not recruiting
  Urinary Incontinence
  
• Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00171587 - Active, not recruiting
  Tumors; Neoplasm Metastasis
  
• XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00212615 - Active, not recruiting
  C04.588.274.476.411.307
  
• A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
  ClinicalTrials.gov Identifier: NCT00234988 - Active, not recruiting
  Obesity
  
• Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1)(Study P03672AM3)
  ClinicalTrials.gov Identifier: NCT00243230 - Active, not recruiting
  HIV Infections
  
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00277472 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00280540 - Active, not recruiting
  Hypertension
  
• Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00287950 - Active, not recruiting
  Neuroblastoma
  
• Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome
  ClinicalTrials.gov Identifier: NCT00303004 - Active, not recruiting
  Eisenmenger Syndrome
  
• Combination Chemotherapy in Treating Patients With Resected Colon Cancer
  ClinicalTrials.gov Identifier: NCT00378716 - Active, not recruiting
  Colorectal Cancer
  
• Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00398554 - Active, not recruiting
  Lymphoma
  
• Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
  ClinicalTrials.gov Identifier: NCT00400777 - Active, not recruiting
  Hypertension
  
• Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00316095 - Active, not recruiting
  Hypertension; Dyslipidemias
  
• ACT MALI: Treatment of Malaria Based on Combination Therapies
  ClinicalTrials.gov Identifier: NCT00452907 - Active, not recruiting
  Malaria
  
• Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00250926 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00347971 - Active, not recruiting
  Lymphoma, Non-Hodgkin
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00019253 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00274807 - Active, not recruiting
  Leukemia
  
• A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
  ClinicalTrials.gov Identifier: NCT00345163 - Active, not recruiting
  Glioblastoma
  
• Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00416377 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00416832 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00417014 - Active, not recruiting
  Lymphoma
  
• VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00505700 - Active, not recruiting
  Leukemia
  
• Avoiding Cardiovascular Events Through COMbination Therapy in Patients Living With Systolic Hypertension: ACCOMPLISH
  ClinicalTrials.gov Identifier: NCT00170950 - Active, not recruiting
  Hypertension
  
• A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1
  ClinicalTrials.gov Identifier: NCT00239148 - Active, not recruiting
  Type 1 Diabetes
  
• A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1
  ClinicalTrials.gov Identifier: NCT00239187 - Active, not recruiting
  Type 2 Diabetes
  
• Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00329368 - Active, not recruiting
  Cancer
  
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00337246 - Active, not recruiting
  Leukemia
  
• Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
  ClinicalTrials.gov Identifier: NCT00354523 - Active, not recruiting
  Solid Tumor; Thyroid Cancer
  
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00416819 - Active, not recruiting
  Lymphoma
  
• Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
  ClinicalTrials.gov Identifier: NCT00439738 - Active, not recruiting
  Hypertension
  
• ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00533169 - Active, not recruiting
  Neuroblastoma
  
• A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH
  ClinicalTrials.gov Identifier: NCT00510406 - Active, not recruiting
  Lower Urinary Tract Symptoms; Prostatic Hyperplasia
  
• Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
  ClinicalTrials.gov Identifier: NCT00244712 - Active, not recruiting
  HIV Infections